Anaesthetic assessment and management of cardiac patients for non-cardiac surgery. Part 2: Management.
In an earlier article in this journal (June 1999) we discussed the risk that the presence of cardiac disease poses to patients undergoing non-cardiac surgery. We outlined factors in the patient's medical history, examination findings and the value of various tests in arriving at an overall assessment of risk for any given patient. In this article we concentrate on the management of these patients as they undergo surgery itself. We shall consider what measures may usefully be employed in order to minimise the risk of an adverse cardiac event occurring in the perioperative period.
Shaw
A
A
Department of Anaesthetics, Harefield Hospital, Middlesex, UK.
Boscoe
M J
MJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002407:Catheterization, Swan-Ganz; D017548:Echocardiography, Transesophageal; D006801:Humans; D015994:Incidence; D007430:Intraoperative Care; D007431:Intraoperative Complications / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D017202:Myocardial Ischemia / Q000150:complications / Q000000981:diagnostic imaging; D011182:Postoperative Care; D011300:Preoperative Care / Q000379:methods; D012308:Risk Management
D000319:Adrenergic beta-Antagonists